Skip to main navigation

Skip to main content

About
- Executive Team
- Board of Directors
- How We Operate
  Quality Capabilities
- Locations
- News
Products
Contract Manufacturing
Investors
Careers
Contact
- Contact Us
- Locations

News

Overview

Site Search

Year

04/19/2022

ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022

04/11/2022

ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets

03/22/2022

ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors

03/15/2022

ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth

03/07/2022

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022

02/24/2022

ANI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team

01/24/2022

ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders

01/03/2022

ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 18 of 18

Contact Us

INVESTOR CONTACT

In-Site Communications, Inc.
Lisa M. Wilson

212-452-2793
IR@anipharmaceuticals.com

Quick Links

SEC Filings
Investor FAQs
Information Request Form

Investor Email Alerts

Email Address *

Unsubscribe

Products
Investors
Careers
Contact Us
Privacy Policy
Terms of Use
Accessibility

© Copyright 2022 ANI Pharmaceuticals, Inc.

follow us on linkedin
follow us on youtube